SOX4 and breast cancer: One of the important findings in this study is that ectopic expression of SOX4 increases the susceptibility of breast cancer cells to paclitaxel, suggestive of the potential use of paclitaxel in breast cancer treatment if the expression level of SOX4 in the tumor is high.